 you know, they saw more and more opportunity. And as pharma has grown and as pharmaceuticals have grown, they've seen an opportunity. And this is why I get back to ethics, because if you're operating these, how do you know, how do you live with yourself taking these types of profit margins, uh, at the, at the hands of consumer consumers who just, they can barely pay their bills. So, you know, I just, I have a moment or two left. Um,